Literature DB >> 25610509

A six-minute step test protocol for the investigation of dyspnea.

Aline Aparecida Simsic1, Ada Clarice Gastaldi2, José Baddini-Martinez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25610509      PMCID： PMC4301253          DOI： 10.1590/S1806-37132014000600012

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  5 in total

Review 1.  The use of step tests for the assessment of exercise capacity in healthy subjects and in patients with chronic lung disease.

Authors:  Carlos Henrique Silva de Andrade; Reinaldo Giovanini Cianci; Carla Malaguti; Simone Dal Corso
Journal:  J Bras Pneumol       Date:  2012 Jan-Feb       Impact factor: 2.624

2.  Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  T Y Martinez; C A Pereira; M L dos Santos; R M Ciconelli; S M Guimarães; J A Martinez
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

3.  A step test to assess exercise-related oxygen desaturation in interstitial lung disease.

Authors:  S Dal Corso; S R Duarte; J A Neder; C Malaguti; M B de Fuccio; C A de Castro Pereira; L E Nery
Journal:  Eur Respir J       Date:  2006-10-18       Impact factor: 16.671

4.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

5.  A symptom-limited incremental step test determines maximum physiological responses in patients with chronic obstructive pulmonary disease.

Authors:  Simone Dal Corso; Anderson Alves de Camargo; Meyer Izbicki; Carla Malaguti; Luiz Eduardo Nery
Journal:  Respir Med       Date:  2013-07-14       Impact factor: 3.415
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.